Transplant Box - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, transplant box market size in 2026 is estimated at USD 193.25 million, growing from 2025 value of USD 179.52 million with 2031 projections showing USD 279.27 million, growing at 7.65% CAGR over 2026-2031.

This report is Segmented by Organ Type (Heart, Liver, Lung, Kidney, Pancreas, and More), Preservation Technology (Static Cold Storage Boxes, Normothermic Machine Perfusion Devices, and More), End User (Hospitals & Transplant Centers, Organ Procurement Organisations, and More) and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Transplant Box Market Trends and Insights

Increasing Volume of Multi-Organ Transplants in Ageing and Diabetic Populations

Record organ recovery volumes in 2024 confirm that older and diabetic cohorts are driving sustained procedure growth. Higher prevalence of end-stage renal disease and cardiometabolic complications requires longer preservation windows that static cold storage cannot guarantee. Emerging economies mirrored this rise, highlighting untapped regional demand. Allocation systems now prioritize sicker patients, which often adds inter-state or cross-border travel to procurement logistics. These factors collectively elevate the clinical necessity for advanced devices across the transplant box market.

Government & NGO Programs Expanding Donor Registries

Legislative changes such as Ireland's opt-out Human Tissue Act 2024, in effect from June 2025, instantly enlarge donor pools. Japan's coordinator certification framework and India's expanded brain-death criteria similarly shorten consent cycles and raise utilization rates. The WHO strategy that calls for every member state to meet transplant demand by 2035 institutionalizes this momentum. Expanding donor availability directly lifts shipment volumes and places fresh emphasis on reliable, data-rich preservation hardware.

High Capital & Per-Use Cost of Advanced Transplant Boxes

Liver transplant expenses rose 10.9% after allocation policy revisions, underscoring the sensitivity of overall costs to logistics inputs. Incremental cost-effectiveness analyses frequently exceed USD 100,000 per quality-adjusted life year, stretching reimbursement thresholds. Consumable kits and single-use cartridges add recurring cost layers that impede broad deployment in mid-tier centers.

Other drivers and restraints analyzed in the detailed report include:

1. Shift from Static Cold Storage to Portable Normothermic Perfusion Systems
2. Hospital Demand for Real-Time Organ-Condition Analytics
3. Complex Multi-Jurisdictional Regulatory Clearances

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Kidney devices contributed 37.80% of the transplant box market in 2025, benefiting from both deceased and living donor programs. Wider acceptance of ABO-incompatible procedures and record 8,200 kidney transplants performed by a single network in 2024 demonstrate deep installed demand. Conversely, lung preservation shows the fastest 11.88% CAGR as ex-vivo perfusion revives marginal grafts, a development that could lift the transplant box market size for pulmonary applications by mid-decade. Heart, liver, and pancreas boxes continue steady uptake, and early-stage work in intestinal and vascular-composite preservation hints at future expansion vectors.

The second growth driver is the widening perimeter of acceptable donor-recipient travel times. Normothermic lung and heart solutions allow 6-20 hour windows without raising ischemia-reperfusion risks, letting clinicians consider intercontinental matches and thereby stimulating regional volume. As transplant registries diversify, organ-specific demand patterns will continue to recalibrate production and R&D allocations across vendors operating in the transplant box market.

Complete Report Scope:

• By Organ Type
  • Heart
  • Liver
  • Lung
  • Kidney
  • Pancreas
  • Others
• By Preservation Technology
  • Static Cold Storage Boxes
  • Normothermic Machine Perfusion Devices
  • Hypothermic Machine Perfusion Devices
  • Others
• By End User
  • Hospitals & Transplant Centers
  • Organ Procurement Organisations (OPOs)
  • Military & Emergency Medical Services
  • Research Institutes
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retains leadership with 37.20% of global revenue in 2025 owing to robust healthcare infrastructure and rigorous yet navigable regulatory pathways. The United States accounts for the majority of regional sales, supported by sustained double-digit revenue growth reported by leading vendors. Cross-border agreements with Canada and Mexico facilitate broader organ sharing and strengthen procurement logistics, thereby maintaining high device utilization.

Europe follows with sophisticated transplant networks and progressive regulations. The new SoHO rules harmonize technical standards, positioning the bloc for accelerated adoption of dynamic perfusion devices. Countries such as Germany, France, and Spain show notable investment in donor-care units, which increase yields and reduce total costs, thus enhancing device ROI.

Asia-Pacific is the fastest-growing territory, recording a 10.42% CAGR through to 2031. China's voluntary donation system, Japan's coordinator certifications, and India's record transplant volumes collectively generate an expanding customer base. Governments are also funding new transplant centers and procurement hubs, prerequisites for large-scale device deployment. South America, the Middle East, and Africa hold significant latent demand, but limited reimbursement and logistical challenges constrain immediate scale. Gradual infrastructure improvements are likely to unlock incremental opportunities over the second half of the forecast period, incrementally lifting overall transplant box market growth.

1. TransMedics Inc.
2. Organ Recovery Systems
3. Getinge (Paragonix Technologies, Inc.)
4. Institut Georges Lopez (IGL)
5. OrganOx Ltd.
6. Xvivo Perfusion
7. Bridge to Life Ltd.
8. Hibernicor
9. Northwestern Medicine
10. Waters Medical Systems
11. Preservation Solutions Inc.
12. Ebers Medical Technology SL
13. CryoLife
14. Lifeline Scientific
15. Medtronic
16. W. L. Gore & Associates
17. Terumo
18. Shenzhen Lifotronic Technology Co.
19. Avive Biomedical
20. OCS Logistics LLC

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support